scholarly journals Effect of a single intravitreal bevacizumab injection on different optical coherence tomographic patterns of diabetic macular oedema

Eye ◽  
2013 ◽  
Vol 27 (6) ◽  
pp. 716-721 ◽  
Author(s):  
A Koytak ◽  
M Altinisik ◽  
E Sogutlu Sari ◽  
O Artunay ◽  
J C Umurhan Akkan ◽  
...  
Keyword(s):  
Macular Oedema ◽  
Diabetic Macular Oedema ◽  
Intravitreal Bevacizumab ◽  
Optical Coherence ◽  
Intravitreal Bevacizumab Injection ◽  
Bevacizumab Injection

scholarly journals Visual outcomes in Patients with Diabetic Macular Oedema undergoing Cataract Surgery with or without Intravitreal Bevacizumab

1970 ◽  
Vol 12 (3) ◽  
pp. 135-139
Author(s):  
Mazhar Hassan Hassan ◽  
Aziz Ur Rehman ◽  
Umair Qidwai ◽  
Rashid Alvi ◽  
Nasir Bhatti ◽  
...  
Keyword(s):  
Visual Acuity ◽  
Cataract Surgery ◽  
Macular Oedema ◽  
Diabetic Macular Oedema ◽  
Intravitreal Bevacizumab ◽  
Control Group ◽  
Open Label ◽  
Intravitreal Bevacizumab Injection ◽  
Randomised Controlled ◽  
Bevacizumab Injection

Aims: To evaluate the efficacy of a single intravitreal bevacizumab injection after cataract surgery for the management of postoperative decrease in vision in patients with diabetic macular oedema.Methods: In this randomised controlled open-label parallel group study of 60 patients with diabetic macular oedema and lens opacity (grade ≥3), 30 eyes received a single intravitreal bevacizumab injection after cataract surgery, and 30 control eyes did not receive bevacizumab. The primary endpoint was change in best-corrected visual acuity 6 weeks after operation compared with that at baseline using the Snellen visual acuity chart.Results: Postoperative visual acuity was significantly different between the group receiving bevacizumab and the control group (p<0.005). All patients in the bevacizumab group had postoperative visual acuities above 6/18 with 27 patients having visual acuities of 6/12 or better compared with 6 patients in the control group. None of the patients in the bevacizumab group had visual acuities less than 6/18 compared with 11 patients in the control group.Conclusion: Intravitreal bevacizumab after cataract surgery appears to be beneficial for preventing postoperative visual loss in eyes with diabetic retinopathy by reducing the risk of macular thickening.

Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema

2008 ◽  
Vol 86 (4) ◽  
pp. 365-371 ◽  
Author(s):  
Wael Soliman ◽  
Martin Vinten ◽  
Birgit Sander ◽  
Kamell Abd El-Naser Soliman ◽  
Sameer Yehya ◽  
...  
Keyword(s):  
Optical Coherence Tomography ◽  
Macular Oedema ◽  
Diabetic Macular Oedema ◽  
Intravitreal Bevacizumab ◽  
Vessel Diameter ◽  
Optical Coherence
Sign in / Sign up

Export Citation Format

Share Document